1. Home
  2. BHE vs TMDX Comparison

BHE vs TMDX Comparison

Compare BHE & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Benchmark Electronics Inc.

BHE

Benchmark Electronics Inc.

HOLD

Current Price

$82.36

Market Cap

2.9B

Sector

Technology

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$83.89

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHE
TMDX
Founded
1979
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.6B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
BHE
TMDX
Price
$82.36
$83.89
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$55.00
$148.22
AVG Volume (30 Days)
384.7K
937.7K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
0.94%
N/A
EPS Growth
N/A
382.18
EPS
0.91
0.61
Revenue
$2,659,108,000.00
$605,494,000.00
Revenue This Year
$7.03
$24.25
Revenue Next Year
$6.57
$18.75
P/E Ratio
$90.52
$131.49
Revenue Growth
0.11
37.13
52 Week Low
$35.97
$60.11
52 Week High
$100.41
$156.00

Technical Indicators

Market Signals
Indicator
BHE
TMDX
Relative Strength Index (RSI) 49.46 58.69
Support Level $79.59 $66.18
Resistance Level $87.59 $140.79
Average True Range (ATR) 4.22 4.14
MACD 0.59 0.63
Stochastic Oscillator 72.86 79.36

Price Performance

Historical Comparison
BHE
TMDX

About BHE Benchmark Electronics Inc.

Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia, and Europe, of which key revenue is derived from the Americas.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: